K-numberK253370
Device nameLOGIQ Totus
ApplicantGE Medical Systems Ultrasound and Primary Care Diagnostics
Product codeIYN
Device classClass II
Decision dateJan 8, 2026
DecisionSubstantially Equivalent
Regulation892.1550
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The LOGIQ Totus is a full-featured diagnostic ultrasound system consisting of a mobile console with digital acquisition, processing, and display capability. It is intended for use by qualified physicians for ultrasound evaluation across multiple clinical applications including fetal/obstetrics, abdominal, cardiac, peripheral vascular, musculoskeletal, and transesophageal imaging, operating in multiple modes (B, M, Doppler, Color Doppler, Harmonic Imaging, Elastography, and combined modes).

Technological characteristics

The proposed device employs the same fundamental scientific technology as its predicate. Key differences include addition of four new probes (C2-9-D, L4-20t-D, L3-9i-D, 6Tc-RS migrated from LOGIQ E10s), new software features including Auto Renal Measure Assistant and Ultrasound Guided Fat Fraction, GPU replacement (NVIDIA T1000 to T1000E), and various interface and workflow improvements. Acoustic power levels remain below FDA limits.

Test standards cited

The device complies with ANSI AAMI ES60601-1, IEC 60601-1 Edition 3.2, IEC 60601-2-37 Edition 3.0, IEC 60601-1-2 Edition 4.1, IEC 62359 Edition 2.1, ISO 10993-1, ISO 14971, NEMA PS 3.1-3.20, and AAMI TIR69:2017. Testing included acoustic output, biocompatibility, cleaning/disinfection, thermal, electrical, electromagnetic, and mechanical safety evaluations.

Substantial equivalence argument

The proposed LOGIQ Totus is substantially equivalent to the predicate LOGIQ Totus (K232381) based on identical intended use for diagnostic ultrasound imaging, same imaging modes and fundamental technology, similar measurement and image capture capabilities, and compliance with recognized safety standards. Clinical studies demonstrated the new UGFF feature maintains strong correlation with MRI-PDFF across multiple populations, and migrated software features were previously cleared on other predicate devices.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →